Published in Developmental Cell, the Mitchell Lab’s discovery could someday affect scientists’ understanding of the way centriole duplication goes awry in cancer development.
A new class of experimental drug-like small molecules is showing great promise in targeting a brain enzyme to prevent early memory loss in Alzheimer’s disease.